Natalia Barajas Castrellon: FRONTIER2 Results Show Potential for Prophylactic Therapy in Hemophilia A
Natalia Barajas Castrellon, Rared Associate Director Medical and Marketing at Novo Nordisk, reposted from Novo Nordisk on LinkedIn:
”New data from Novo Nordisk in hemophilia A, published in NEJM Group, reinforces the strategic direction of the portfolio.
The results highlight the potential of an investigational prophylactic therapy to reduce bleeding episodes across patient segments, including those with inhibitors – while enabling greater treatment individualization, a key driver of next-generation care models.
This builds on well-established progress in hemophilia, where advances in prophylaxis have materially improved quality of life and extended life expectancy toward that of the general population.”
Novo Nordisk shared on LinkedIn about a recent article by Maria Elisa Mancuso et al, published in NEJM, adding:
”Results from Novo Nordisk’s hemophilia research published in NEJM Group highlights the potential of an investigational preventive bleed treatment option to help people living with hemophilia A, with or without inhibitors.
Learn more in the press release.”
Title: Mim8 Bispecific Antibody Prophylaxis in Hemophilia A with or without Inhibitors
Authors: Maria Elisa Mancuso, Anthony K.C. Chan, Chandrakala Shanmukhaiah, Chuhl Joo Lyu, Joanna Zdziarska, Johnny Mahlangu, Lize F.D. van Vulpen, Pratima Chowdary, Renchi Yang, Steven R. Lentz, Tadashi Matsushita, Wan Hui Ong Clausen, Ilgiz Rakhmatullin, Johannes Oldenburg for the FRONTIER2 Investigators

Stay updated on all scientific advances with Hemostasis Today.
-
Nov 16, 2026, 15:35Jim Hoffman: Could Blood Purification Change the Fight Against Cancer?
-
Nov 16, 2026, 15:16How Do Artificial Hearts Affect Platelet Function? – Platelets Journal
-
Nov 16, 2026, 15:10Assessing Coagulation Activation in DOAC – Treated Patients – JTH
-
Nov 16, 2026, 15:00Davide Antonio Mei: Should Anticoagulation Continue After AF Ablation?
-
Nov 16, 2026, 14:55Danielle Boyle: Beyond Platelet Counts – Why Patient Stories Matter
-
Nov 16, 2026, 14:28Jan Sloves: The Future of Vascular Ultrasound
-
Nov 16, 2026, 13:49Bahman Rasouli: A Rare Vascular Manifestation of Recurrent Papillary Thyroid Carcinoma
-
Nov 16, 2026, 13:28Muhammad Danyal: Platelet Patterns in Hepatitis B and C
-
Nov 16, 2026, 12:52Frank Nocken: Alzheimer’s Research Expands Beyond Amyloid-Based Treatments